1. Home
  2. ABCL vs NAGE Comparison

ABCL vs NAGE Comparison

Compare ABCL & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • NAGE
  • Stock Information
  • Founded
  • ABCL 2012
  • NAGE 1999
  • Country
  • ABCL Canada
  • NAGE United States
  • Employees
  • ABCL N/A
  • NAGE N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • NAGE Medicinal Chemicals and Botanical Products
  • Sector
  • ABCL Health Care
  • NAGE Health Care
  • Exchange
  • ABCL Nasdaq
  • NAGE Nasdaq
  • Market Cap
  • ABCL 772.9M
  • NAGE 861.0M
  • IPO Year
  • ABCL 2020
  • NAGE N/A
  • Fundamental
  • Price
  • ABCL $3.41
  • NAGE $13.44
  • Analyst Decision
  • ABCL Strong Buy
  • NAGE Strong Buy
  • Analyst Count
  • ABCL 4
  • NAGE 3
  • Target Price
  • ABCL $8.33
  • NAGE $16.67
  • AVG Volume (30 Days)
  • ABCL 6.1M
  • NAGE 908.5K
  • Earning Date
  • ABCL 08-05-2025
  • NAGE 08-06-2025
  • Dividend Yield
  • ABCL N/A
  • NAGE N/A
  • EPS Growth
  • ABCL N/A
  • NAGE N/A
  • EPS
  • ABCL N/A
  • NAGE 0.18
  • Revenue
  • ABCL $23,114,000.00
  • NAGE $107,925,000.00
  • Revenue This Year
  • ABCL N/A
  • NAGE $26.21
  • Revenue Next Year
  • ABCL $66.89
  • NAGE $20.91
  • P/E Ratio
  • ABCL N/A
  • NAGE $75.77
  • Revenue Growth
  • ABCL N/A
  • NAGE 29.77
  • 52 Week Low
  • ABCL $1.89
  • NAGE $2.31
  • 52 Week High
  • ABCL $3.68
  • NAGE $14.49
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 76.76
  • NAGE N/A
  • Support Level
  • ABCL $3.10
  • NAGE N/A
  • Resistance Level
  • ABCL $3.57
  • NAGE N/A
  • Average True Range (ATR)
  • ABCL 0.25
  • NAGE 0.00
  • MACD
  • ABCL 0.10
  • NAGE 0.00
  • Stochastic Oscillator
  • ABCL 89.68
  • NAGE 0.00

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About NAGE Niagen Bioscience Inc. Common Stock

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

Share on Social Networks: